ARBEL IRIT has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Based on the SEC filing context provided, Irit Arbel is listed as a Director of BrainStorm Cell Therapeutics Inc. as of the most recent filing on 2026-05-29. The available information does not include detailed biographical data, education, or prior roles beyond this board membership. BrainStorm Cell Therapeutics is a publicly traded biotech company focused on stem cell-based therapies. Arbel’s role is governance-oriented (board director), contributing to oversight of corporate strategy, financial reporting, and risk management. No additional public biographical details are available within the provided SEC context.
Role
Director
Notability
60/100
Board memberships
BrainStorm Cell Therapeutics Inc.
Awards & honors
Board member of BrainStorm Cell Therapeutics Inc. (as of 2026)
Based on the SEC filing context provided, Irit Arbel is listed as a Director of BrainStorm Cell Therapeutics Inc. as of the most recent filing on 2026-05-29. The available information does not include detailed biographical data, education, or prior roles beyond this board membership. BrainStorm Cell Therapeutics is a publicly traded biotech company focused on stem cell-based th…
How many SEC Form 4 filings has ARBEL IRIT submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of ARBEL IRIT's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
